Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

8000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-09-30

Study Completion Date

2003-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will demonstrate if a treatment optimization program has an impact on the satisfaction with Viagra treatment in men with erectile dysfunction

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction

NCT00245258

Impotence

COMPLETED PHASE4

Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose

NCT00143260

Impotence

COMPLETED PHASE4

A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile Dysfunction

NCT00654914

Erectile Dysfunction

COMPLETED PHASE3

Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk

NCT00874185

Erectile Dysfunction

COMPLETED

Evaluation of LEVITRA to Advance the Treatment of Erectile Dysfunction

NCT00664833

Erectile Dysfunction

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Impotence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Treatment Optimization Program (educational material)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male subjects above age of majority for whom sildenafil is prescribed for the first time within the usual practice of medicine

Exclusion Criteria

* Male subjects who have used any ED medical treatments over the last month, with the exception of testosterone and/or herbal therapies
* Subjects who do not have the possibility of viewing the video either through a computer, VCR or a DVD

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No